Abstract
The process of aging is associated with structural and functional changes occurring in the living organism and often expressed in gradual deterioration and decline in performance. These impairments result in changes in host resistance and are perhaps the major factors in the emergence of neoplasia in those elderly who have survived the ravages of vascular diseases, accidents, and infection. The hematologic neoplasms are generally diseases of higher incidence with advancing age. These disorders are uncommon under the age of 40; although they do not represent a national health hazard, they are not rare. Malignant lymphomas have an incidence of 82 cases per million. The occurrence of the lymphomas and the ability of the host to deal with them as well as responses to therapy are all modified by advanced age and will be discussed in this chapter.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Mackay, R. R., 1972, Aging and immunologic function in man, Gerontologia 18: 285.
Diaz-Jouanen, E., Strickland, R., and Williams, S. R., 1975, Studies of human lymphocytes in the new born and the aged, Am. J. Med. 58: 620.
Young, R. C., Corder, M. P., and Haynes, H. A., 1972, Delayed hypersensitivity in Hodgkin’s disease: A study of 103 patients, Am. J. Med. 52: 63–71.
Jones, S. E., Griffith, K., and Dombrowski, P., 1977, Immunodeficiency in patients with non-Hodgkin’s lymphoma, Blood 49: 335–344.
Moore, D. F., Migliore, P. H., and Shullenberger, C. C., 1970, Moncoclonal macroglobulinemia in malignant lymphoma, Ann. Intern. Med. 72: 43.
MacMahon, B., 1957, Epidemiologic evidence on the nature of Hodgkin’s disease, Cancer 10: 1045–1054.
Greco, R. S., Acheson, R. S., and Foote, F. M., 1974, Hodgkin’s disease in Connecticut from 1935 to 1962: The bimodal incidence curve in the general population and survival in untreated patients, Arch. Intern. Med. 134: 1039–1042.
Newell, G. R., Cole, S. R., Miettinen, O. S., and MacMahon, B., 1970, Age differences in the histology of Hodgkin’s disease, J. Nat. Cancer, Inst. 45: 311–317.
Lokich, J. J., Pinkus, G. S., and Moloney, W. C., 1974, Hodgkin’s disease in the elderly, Oncology 29: 484–500.
Goodman, R. L., Piro, A. J., and Hellman, S., 1976, Can pelvic irradiation be omitted in patients with pathologic stages IA and IIA Hodgkin’s disease? Cancer 37: 2834–2839.
Hellman, S., 1979, An evaluation of total nodal irradiation as treatment for stage IIIA Hodgkin’s disease, Cancer 43: 1255–1261.
DeVita, V. T., Hubbard, S. M., Moxley, J. H., Ill, 1983, The Cure of Hodgkin’s Disease with Drugs, yearbook Medical Publishers, Inc., Chicago, pp. 277–301.
Bonadonna, G., Santoro, A., Bonfante, V., and Valagussa, P., 1982, Cyclic delivery of MOOP and ABVD combinations in stage IV Hodgkin’s disease: Rationale, background studies and recent results, Cancer Treat Rep 66: 881–887.
Penn, I., 1975, The incidence of malignancies in transplant recipients, Transplant Proc 7: 323–326.
Jones, S. E., Fuks, Z., Bull, M., Kadin, M. E., Dorfman, R. F., Kaplan, H. S., Rosenberg, S. A., and Kim, H., 1973, Non-Hodgkin’s lymphomas IV. Clinico pathological correlation in 405 cases Cancer 31: 806–823.
Jones, S. E., Fuks, A., Kaplan, H. S., and Rosenberg, S. A., 1973, Non-Hodgkin’s lymphomas. V. Results of radiotherapy, Cancer 32: 682–691.
Berard, C. W, Greene, M. H., Jaffe, E. S, Magrath, I, and Ziegler, J., 1981, NIH conference. A multi disciplinary approach to non-Hodgkin’s lymphomas, Ann. Intern. Med. 94 (2): 218–235.
Portlock, C. S., and Rosenberg, S. A., 1979, No initial therapy for stage III and IV non-Hodgkin’s lymphomas of favourable histologic types, Ann. Intern. Med. 90: 10–13.
Canellos, G. P., Skarin, A. T., and Rosenthal, D. S., 1981, Methotrexate as a single agent in combination chemotherapy for the treatment of non-Hodgkin’s lymphomas of unfavourable histology, Cancer Treat Rep. 65 (Suppl. 1): 125–129.
Armitage, J. O., and Potter, J. F., 1984, Aggressive chemotherapy for diffuse histiocytic lymphoma in the elderly: Increased complications with advancing age, J. Am. Geriatr. Soc. 32: 269–273.
Case, D. C., Jr., Lee, B. J., II, and Clarkson, B. D., 1977, Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine, BCNU: M2 protocol, Am. J. Med. 63: 897–903.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Plenum Publishing Corporation
About this chapter
Cite this chapter
Gaddipati, J.C., Friedland, M.L., Arlin, Z. (1986). Diagnosis and Treatment of Malignant Lymphomas in the Elderly. In: Gambert, S.R. (eds) Contemporary Geriatric Medicine. Contemporary Geriatric Medicine, vol 2. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5000-2_12
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5000-2_12
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5002-6
Online ISBN: 978-1-4684-5000-2
eBook Packages: Springer Book Archive